We spoke to new Sterling Energy CEO Tony Hawkins about the latest changes happening at the company. Watch the full video here.
LONDON, Sept 22 (Reuters) - Drugmaker AstraZeneca is harnessing the wisdom of crowds to help mix tomorrow's cancer drug cocktails. The company said on Tuesday its decision to release preclinical data from more than 50 of its medicines was unprecedented in scale and would help accelerate the
By John Miller BASEL, Sept 18 (Reuters) - Visible from neighbouring France and Germany, a new 41-storey skyscraper that drugs company Roche opened near the river Rhine on Friday reaches 178 meters into the sky, easily the tallest building in Switzerland. The 550-million Swiss franc (
(Adds analyst estimates on Jardiance sales and Lilly earnings, details on study, medical comment; updates share price) By Ransdell Pierson Sept 17 (Reuters) - Eli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in patients with type 2 diabetes at risk of heart attack an
(Updates price, adds stock symbol) ** Shares of Eli Lilly and Co up 6 pct at $89.74, giving the biggest boost to the S&P 500, following positive drug news ** Its new Jardiance pill slashed deaths by 32 pct in a study of 7,000 patients with type 2 diabetes at risk of heart attack and s
(ShareCast News) - Exane BNP Paribas took a look at UK asset managers, noting that their shares have sold off sharply, making for an enticing entry point. "Equity market volatility is a risk to inflows, but historically the impact has been temporary and flows into other asset classes do not suffer a
(ShareCast News) - Deutsche Bank upgraded AstraZeneca to 'buy' from 'hold' and raised its price target to 5,700p from 4,850p. The bank said it's increasingly confident in AstraZeneca's ability to deliver a return to strong growth from a base in 2017. "We have increased our outer year sales and earn